Market Overview
The global Neurosurgery Devices Market was valued at USD 12.9 Billion in 2024 and is projected to reach USD 32.7 Billion by 2033. It is expected to expand at a CAGR of 10.37% during the forecast period 2025-2033. Neurosurgery devices are critical tools for surgeries and treatments related to the central and peripheral nervous systems, aiding in the management of diseases such as Parkinson’s, Alzheimer’s, depression, and traumatic brain injuries.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Neurosurgery Devices Market Key Takeaways
- Current Market Size: USD 12.9 Billion in 2024
- CAGR: 10.37%
- Forecast Period: 2025-2033
- Neurosurgery devices encompass neurostimulation, neurointerventional, navigation, and cerebrospinal fluid management devices.
- Increasing prevalence of neurological disorders is a significant growth driver.
- Rising geriatric population prone to neurological ailments supports market expansion.
- Advancements in minimally invasive equipment and growing preference for neuroendoscopy surgeries are market growth factors.
- Improved healthcare infrastructure and extensive R&D activities will propel the market further.
Request for a Free Sample Report: https://www.imarcgroup.com/neurosurgery-devices-market/requestsample
Market Growth Factors
The prominent factor that leads to the expansion of the market for neurosurgery devices is the increasing case count of various neurological diseases all over the world. A range of conditions such as Parkinson’s disease, Alzheimer’s disease, depression, epilepsy, and traumatic brain and spinal cord injuries require the use of advanced devices for their accurate diagnosis, prevention, and treatment. The healthcare facilities are forced by this rising number of cases to equip themselves with advanced neurosurgery devices, hence the demand and market growth increase.
Moreover, the worldwide aging population that is becoming more vulnerable to neurological and other health problems is a major factor for the market growth. The increase in the elderly population means that the demand for effective neurosurgical interventions will also rise. In addition to this, the improvement of health and the increased public awareness about the different treatment options for neurological disorders are also factors that contribute to the use of neurosurgery devices in hospitals and clinics.
Market growth is also very much dependent on technological innovations. The invention of new minimally invasive (MI) tools such as flow diversion, liquid embolic and clot retrieval devices, neuroendovascular stents, and balloon catheters allows for higher surgical precision and better patient outcomes. These innovations, together with the increased preference of neuroendoscopy surgeries instead of traditional brain surgeries, lead to the increased use of advanced neurosurgery devices, hence the market expands further.
Market Segmentation
By Product Type:
- Neurostimulation Devices: Devices used to send electrical impulses to target nerves, aiding in treatments like deep brain stimulation.
- Neurointerventional Devices: Instruments designed for minimally invasive procedures involving blood vessels of the nervous system.
- Neurosurgical Navigation Systems: Technology allowing precise surgical navigation during neurosurgeries.
- Cerebral Spinal Fluid (CSF) Management Devices: Tools such as curettes and rongeurs used to manage cerebrospinal fluid during surgeries.
- Others: Additional neurosurgical tools aiding various surgical procedures.
By Application:
- Spinal Cord Stimulation: Devices that electrically stimulate the spinal cord to manage chronic pain.
- Chronic Pain
- Failed Back Surgery Syndrome
- Ischemia
- Deep Brain Stimulation: Procedures targeting neurological disorders with electrical impulses.
- Parkinson’s Disease
- Tremor
- Depression
- Others
- Neuroendoscopy: Minimally invasive endoscopic techniques for neurosurgical procedures.
- Transnasal Neuroendoscopy
- Intraventricular Neuroendoscopy
- Transcranial Neuroendoscopy
By End-User:
- Hospitals: Primary healthcare institutions providing surgical treatment.
- Ambulatory Surgical Centers: Facilities where surgeries are performed without hospital admission.
- Others: Additional settings where neurosurgery devices are utilized.
By Region:
- North America: United States, Canada
- Asia Pacific: China, Japan, India, South Korea, Australia, Indonesia, Others
- Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Others
- Latin America: Brazil, Mexico, Others
- Middle East and Africa
Regional Insights
According to the report, North America is the leading region of the neurosurgery devices market. No exact figures such as regional market share and CAGR are given in the text. The region’s supremacy is being maintained due to its advanced healthcare infrastructure, high prevalence of neurological disorders, and early adoption of advanced neurosurgical technologies.
Key Players
- Abbott Laboratories
- Ackermann Instrumente GmbH
- Adeor Medical AG
- B. Braun Melsungen AG
- Biotronik
- Boston Scientific Corporation
- DePuy Synthes Inc.
- Integra LifeSciences Corporation
- Johnson & Johnson Services Inc.
- Medtronic Plc
- Nevro Corporation
- Nihon Kohden Corporation
- Penumbra Inc.
- Stryker Corporation
Customization Note
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800, United States: +1-201971-6302
